<?xml version='1.0' encoding='UTF-8'?>
<rss xmlns:arxiv="http://arxiv.org/schemas/atom" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" version="2.0">
  <channel>
    <title>q-bio.GN updates on arXiv.org</title>
    <link>http://rss.arxiv.org/rss/q-bio.GN</link>
    <description>q-bio.GN updates on the arXiv.org e-print archive.</description>
    <atom:link href="http://rss.arxiv.org/rss/q-bio.GN" rel="self" type="application/rss+xml"/>
    <docs>http://www.rssboard.org/rss-specification</docs>
    <language>en-us</language>
    <lastBuildDate>Mon, 02 Sep 2024 04:00:58 +0000</lastBuildDate>
    <managingEditor>rss-help@arxiv.org</managingEditor>
    <pubDate>Mon, 02 Sep 2024 00:00:00 -0400</pubDate>
    <skipDays>
      <day>Sunday</day>
      <day>Saturday</day>
    </skipDays>
    <item>
      <title>A note on promotion time cure models with a new biological consideration</title>
      <link>https://arxiv.org/abs/2408.17188</link>
      <description>arXiv:2408.17188v1 Announce Type: cross 
Abstract: We introduce a generalized promotion time cure model motivated by a new biological consideration. The new approach is flexible to model heterogeneous survival data, in particular for addressing intra-sample heterogeneity.</description>
      <guid isPermaLink="false">oai:arXiv.org:2408.17188v1</guid>
      <category>stat.ME</category>
      <category>q-bio.GN</category>
      <category>q-bio.SC</category>
      <pubDate>Mon, 02 Sep 2024 00:00:00 -0400</pubDate>
      <arxiv:announce_type>cross</arxiv:announce_type>
      <dc:rights>http://creativecommons.org/licenses/by/4.0/</dc:rights>
      <dc:creator>Zhi Zhao, Fatih K{\i}z{\i}laslan</dc:creator>
    </item>
    <item>
      <title>Identification of Prognostic Biomarkers for Stage III Non-Small Cell Lung Carcinoma in Female Nonsmokers Using Machine Learning</title>
      <link>https://arxiv.org/abs/2408.16068</link>
      <description>arXiv:2408.16068v2 Announce Type: replace 
Abstract: Lung cancer remains a leading cause of cancer-related deaths globally, with non-small cell lung cancer (NSCLC) being the most common subtype. This study aimed to identify key biomarkers associated with stage III NSCLC in non-smoking females using gene expression profiling from the GDS3837 dataset. Utilizing XGBoost, a machine learning algorithm, the analysis achieved a strong predictive performance with an AUC score of 0.835. The top biomarkers identified - CCAAT enhancer binding protein alpha (C/EBP-alpha), lactate dehydrogenase A4 (LDHA), UNC-45 myosin chaperone B (UNC-45B), checkpoint kinase 1 (CHK1), and hypoxia-inducible factor 1 subunit alpha (HIF-1-alpha) - have been validated in the literature as being significantly linked to lung cancer. These findings highlight the potential of these biomarkers for early diagnosis and personalized therapy, emphasizing the value of integrating machine learning with molecular profiling in cancer research.</description>
      <guid isPermaLink="false">oai:arXiv.org:2408.16068v2</guid>
      <category>q-bio.GN</category>
      <category>cs.AI</category>
      <category>stat.ML</category>
      <pubDate>Mon, 02 Sep 2024 00:00:00 -0400</pubDate>
      <arxiv:announce_type>replace</arxiv:announce_type>
      <dc:rights>http://arxiv.org/licenses/nonexclusive-distrib/1.0/</dc:rights>
      <dc:creator>Huili Zheng, Qimin Zhang, Yiru Gong, Zheyan Liu, Shaohan Chen</dc:creator>
    </item>
  </channel>
</rss>
